Navigation Links
Beckman Coulter Announces Second Quarter 2008 Results
Date:7/25/2008

ll will also be webcast live. The call is accessible to all investors through Beckman Coulter's website at http://www.beckmancoulter.com or at http://www.streetevents.com. When accessing the webcast through the Beckman Coulter site, select "go to IR" under Investor Relations and find the call listed under "What's Ahead". The webcast will be archived on both websites for future on-demand replay through Friday, August 15, 2008.

About Beckman Coulter

Beckman Coulter, Inc., based in Fullerton, California, develops, manufactures and markets products that simplify, automate and innovate complex biomedical tests. More than 200,000 Beckman Coulter systems operate in laboratories around the world, supplying critical information for improving patient health and reducing the cost of care. Recurring revenue, consisting of supplies, test kits, service and operating-type lease payments, represent more than 78% of the company's 2007 revenue of $2.76 billion. For more information, visit http://www.beckmancoulter.com.

Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Such statements contain words such as "may," "will," "might," "expect," "believe," "anticipate," "could," "would," "estimate," "continue," "pursue," or the negative thereof or comparable terminology, and may include without limitation information regarding the company's expectations, goals or intentions regarding the future, including without limitation statements regarding the company's anticipated recurring revenue growth (and that such growth will support future growth and earnings goals), expectations on earnings growth (and that such growth will
'/>"/>

SOURCE Beckman Coulter, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28

Related biology technology :

1. Beckman Coulter Announces Second Quarter 2008 Earnings to be Released on Friday, July 25, 2008, Before Market Opens
2. Upcoming Beckman Coulter Investor Events Second Half of 2008
3. Beckman Coulter to Present at Upcoming Healthcare Conferences
4. Beckman Coulter Announces First Quarter 2008 Results
5. Beckman Coulter Acquires Rights to Hepatitis C Virus
6. Beckman Coulter Declares Quarterly Dividend Payout of $0.17 Per Share
7. The Immune Tolerance Institute Announces Collaboration with Beckman Coulter Establishing a Multiplatform Immunophenotyping/Immunogenotyping Laboratory
8. Beckman Coulter to Present at the 2008 Bear Stearns London Healthcare Conference
9. Beckman Coulter Releases the High-Volume UniCel(R) DxC 880i Integrated Work Cell
10. AcroMetrix Signs Development and Supply Agreement With Beckman Coulter Inc. for Molecular Quality Control Standards
11. Beckman Coulter to Present at the JPMorgan Healthcare Conference

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...r24/PRNewswire-FirstCall/--deCODE,genetics,Inc.(Na...irstday"motionsbytheU.S.BankruptcyCourtfortheDistr...kfiledavoluntarypetitionfor,reliefunderChapter11of...rt. , TheordersissuedbytheBankruptcyCourtallo...eChapter11proceedings.Inparticular,the,companyrece...
(Date:11/24/2009)... recently approved the Promega PowerPlex 16 HS Sys...nerating DNA records for the National DNA Index Sy...PRWEB) -- The FBI recently approved the Promega P...s participating in, or generating DNA records for,...tly contains more than seven million profiles and ...
(Date:11/24/2009).../PRNewswire-FirstCall/--GenomicHealth,Inc.(Nasdaq:...sExecutiveChairman,willpresentatthe21stAnnualPiper...December1,2009at10:00a.m.ET. ,, Toaccessthelive...sittheInvestorRelationssectionofGenomicHealth,sweb...nnecttothewebsiteatleast15minutespriortothebeginni...
(Date:11/23/2009)... In a provocative new study, a University of Utah ...ons the major cause of global warming cannot be ... society builds the equivalent of one new nuclear ... there will be any substantial near-term departure...xide emission rates," says the new paper by Tim Ga...
Breaking Biology Technology:deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Genomic Health to Present at Piper Jaffray Health Care Conference 2Is global warming unstoppable? 2Is global warming unstoppable? 3Is global warming unstoppable? 4
.... 23 Solos Endoscopy, Inc. (Pink,Sheets: SNDY) is...etection,through the use of mammary ductoscopy was...s at the 94th Annual American College of Surgeons ...discussed the understanding of the,ductal lobular ...es. The,Company,s current mission is to continue t...
...ow Has Until April 27, 2009 to Regain Compliance w... Rule -, TUSTIN, Calif., Oct. 23 Peregrine,Pharm...e biopharmaceutical,company developing monoclonal ... virus infections, today announced that it has rec... with additional time to regain,compliance with th...
...Oct. 23 Arena Pharmaceuticals,Inc. (Nasdaq: ARNA...08,financial results after the NASDAQ Global Marke...fternoon, Jack Lief, Arena,s President and,Chief E...ice President,Finance and Chief Financial Officer,...Time (2:00 p.m. Pacific Time) to discuss the third...
Other Biology Technology:Solos Endoscopy, Inc. Applauds American College of Surgeons Review of Advanced Breast Cancer Detection at 94th Annual Clinical Congress 2Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQ's Minimum Bid Price Rule 2Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008 2Arena Pharmaceuticals to Report Third Quarter 2008 Financial Results and to Host Conference Call and Webcast on Thursday, October 30, 2008 3
(Date:11/24/2009)...ts have crystallised a protein that may help gut b...otein could be used by probiotic producers to iden... to people. , "Probiotics need to interact with c...nd if they attach to surfaces in the gut they are ...heir activity," says Dr Nathalie Juge from the Ins...
(Date:11/24/2009)... and the American College of Medical Toxicology (A...e publication of the Journal of Medical Toxicolog...ing in March 2010. It was previously published by...ournal of Medical Toxicology , an international, p...e science and practice of medical toxicology. The...
(Date:11/24/2009)...nstitutes fish food is a matter of debate. A high-...get almost 50 percent of their carbon from trees a...the terrestrial and aquatic ecosystems. , But ne... this is not likely to be true. Algae provide a mu...cording to research published this week in the Pr...
Breaking Biology News(10 mins):A sticky solution for identifying effective probiotics 2Springer and the American College of Medical Toxicology to work together 2Fish food fight: Fish don't eat trees after all, says new study 2Fish food fight: Fish don't eat trees after all, says new study 3Study Showed VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD i 12869 1Study Showed VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD i 12869 2Study Showed VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD i 12869 3Study Showed VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD i 12869 4Study Showed VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD i 12869 5Study Showed VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD i 12869 6Study Showed VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD i 12869 7Study Showed VYVANSE 28R 29 28lisdexamfetamine dimesylate 29 CII Provided Significant Efficacy at 14 Hours After Administration in Adults with ADHD i 12869 8Hormones May Affect Neurological Disease Risk 50513 1Hormones May Affect Neurological Disease Risk 50513 2Study Supports Wider Use of Statins 50510 1Study Supports Wider Use of Statins 50510 2Study Supports Wider Use of Statins 50510 3
... New findings that long-overlooked brain cells pla...e brain call into question one of the basic assump...imaging techniques and could open a new frontier w... , In a paper to appear in the February issue of N...ntists at the University of Rochester Medical Cent...
... By studying a particularly short-lived fish speci...ral compound previously shown to extend lifespan i...ast one vertebrate species. The findings, reported...eriore, Pisa, and colleagues, support the potentia... , The development of drugs able to retard the ons...
... Fish kills, foul odors and closed beaches hit Rho...2001. The culprit was hypoxia, or oxygen depletion...evidence of this "dead zone" could be seen on the ...derwater and discovered a massive mussel die-off. ...central bay, researchers found one reef completely...
Other Biology News:Blood flow in brain takes a twist, affecting views of Alzheimer's 2Blood flow in brain takes a twist, affecting views of Alzheimer's 3Resveratrol prolongs lifespan and delays onset of aging-related traits in a short-lived vertebrate 2'Dead zone' summer killed billions of ocean state mussels 2
...AXIscript In Vitro Transcription Kits synthesize R... 9 cpm/g. High specific activity, single-stranded...says, in situ hybridization, and blot hybridizatio...esis of modest amounts of unlabeled RNA (2-4 g/20u...
Anti-Mouse H60 Monoclonal Antibody, Allophycocyanin Conjugated, Clone 205326 from R&D Systems
SeeDNA co-precipitant from GE Healthcare, formerly Amersham Biosciences
Stat-Pack Aldolase Controls from Caldon Biotech, Inc.
Biology Products: